Sarcoma Clinical Trials

Protocol No.PITitle
OSU-12211Arvinder BhinderA Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel with MORAb-004 in Metastatic Soft Tissue Sarcoma
OSU-9952Albert de la ChapelleStorage of DNA/RNA for the Discovery of Genes Involved in Cancer Predisposition - A Tissue Collection Study
OSU-13014James HanjePre-chemotherapy hepatitis B screening and treatment reduces mortality related to hepatitis B reactivation In patients receiving chemotherapy
OSU-09102Craig HofmeisterA Phase I Study of AR-42 in Adult Patients with Advanced or Recurrent Hematologic Malignancies and Solid Tumors, for Which No Standard Therapy is Available
OSU-10025Stephen PovoskiRestrospective Evaluation of Patients Undergoing Surgery and Same-Day Intravenous Administration of 18F-FDG
OSU-13053Sameek RoychowdhuryPrecision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
OSU-10119Thomas ScharschmidtEstablishing Sarcoma Xenografts
OSU-12066Manisha ShahA Phase I trial of GSK2118436 (BRAFi) and Pazopanib in patients with BRAF-mutated advanced malignant tumors
OSU-12018Robert WesolowskiA Phase 1b Study to Assess the Safety of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu